PSNC Briefing 005/22: Part VIIID – Specials with reimbursement prices relative to commonly identified pack sizes
Published on: 21st February 2022 | Updated on: 15th June 2022
This briefing provides guidance on the new Part VIIID arrangements as FAQs covering the reasons for the introduction of a new section in the Drug Tariff for specials, Part VIIID price-setting processes as well as prescription endorsing and submission requirements. The briefing also includes a table comparing the key differences between Drug Tariff-listed (Part VIIIB and Part VIIID) and non-Tariff specials.
For more information on this topic please email email@example.com